Trefoil Peptides in Lung Diseases

NCT00839735 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2021-02-17

No results posted yet for this study

Summary

The study focuses on trefoil family factor (TFF) peptides in sputum in lung diseases. The investigators hypothesize that TFF peptides are upregulated in lung diseases characterized by mucus hypersecretion.

Conditions

Sponsors & Collaborators

  • Bispebjerg Hospital

    lead OTHER

Principal Investigators

  • Thomas K Lund, MD PhD · Respiratory and Allergy Research Unit

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-02-28
Primary Completion
2010-05-31
Completion
2010-05-31

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00839735 on ClinicalTrials.gov